The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
暂无分享,去创建一个
[1] V. Ehemann,et al. Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines. , 2009, Endocrine-related cancer.
[2] M. Cazzaniga,et al. Is it Time to Test Metformin in Breast Cancer Clinical Trials? , 2009, Cancer Epidemiology Biomarkers & Prevention.
[3] V. Beral,et al. Diabetes and modifiable risk factors for cardiovascular disease: the prospective Million Women Study , 2008, European Journal of Epidemiology.
[4] R. Holman,et al. 10-year follow-up of intensive glucose control in type 2 diabetes. , 2008, The New England journal of medicine.
[5] D. Margolis,et al. Association between serious ischemic cardiac outcomes and medications used to treat diabetes , 2008, Pharmacoepidemiology and drug safety.
[6] F. McAlister,et al. Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review , 2007, BMJ : British Medical Journal.
[7] Alicja Wolk,et al. Diabetes mellitus and risk of breast cancer: A meta‐analysis , 2007, International journal of cancer.
[8] E. Giovannucci,et al. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. , 2007, Gastroenterology.
[9] W. Bilker,et al. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research , 2007, Pharmacoepidemiology and drug safety.
[10] D. Leroith,et al. The role of the IGF system in cancer growth and metastasis: overview and recent insights. , 2007, Endocrine reviews.
[11] Nahum Sonenberg,et al. Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. , 2006, Cancer research.
[12] S. Soedamah-Muthu,et al. Mortality in people with Type 2 diabetes in the UK , 2006, Diabetic medicine : a journal of the British Diabetic Association.
[13] S. Majumdar,et al. Increased Cancer-Related Mortality for Patients With Type 2 Diabetes Who Use Sulfonylureas or Insulin , 2006, Diabetes Care.
[14] S. Larsson,et al. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. , 2005, Journal of the National Cancer Institute.
[15] Dario R Alessi,et al. Metformin and reduced risk of cancer in diabetic patients , 2005, BMJ : British Medical Journal.
[16] J. Lewis,et al. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. , 2004, Gastroenterology.
[17] M. Thun,et al. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. , 2004, American journal of epidemiology.
[18] N. Day,et al. Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer-Norfolk study. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[19] S. Bonovas,et al. Diabetes mellitus and risk of prostate cancer: a meta-analysis , 2004, Diabetologia.
[20] L. Schäffer,et al. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. , 2000, Diabetes.
[21] T. Walley,et al. The UK General Practice Research Database , 1997, The Lancet.
[22] H Jick,et al. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. , 1991, BMJ.